Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Chemically Induced Skin Tumors Arise from Upper Hair Follicle Stem Cells.

Cancer discovery·2026
Same journal

Retraction Casts Doubt on Timing Effects of Immunotherapy.

Cancer discovery·2026
Same journal

mtDNA Lineage Tracing Reveals Monocyte Fate Bias Prior to Tumor Infiltration.

Cancer discovery·2026
Same journal

Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

Cancer discovery·2026
Same journal

DNA, Peptide Vaccines Advance Against GBM.

Cancer discovery·2026
Same journal

AKR1C1 Promotes ADC Resistance by Altering Uptake and Export.

Cancer discovery·2026

Related Experiment Video

Updated: May 9, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Mutations in ERBB3 drive tumorigenesis

    Cancer Discovery
    |July 13, 2013
    PubMed
    Summary
    This summary is machine-generated.

    Somatic mutations in ERBB3 hotspots drive cancer growth in some individuals. These alterations activate oncogenic signaling pathways, offering potential therapeutic targets for specific human tumors.

    More Related Videos

    Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
    15:05

    Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

    Published on: May 20, 2020

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    Related Experiment Videos

    Last Updated: May 9, 2026

    Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
    09:37

    Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

    Published on: August 25, 2021

    Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
    15:05

    Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

    Published on: May 20, 2020

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • The Epidermal Growth Factor Receptor (EGFR) family plays a crucial role in cell growth and differentiation.
    • ERBB3 (also known as HER3) is a member of the EGFR family and is known to interact with other family members.
    • Dysregulation of ERBB3 signaling has been implicated in various cancers.

    Purpose of the Study:

    • To investigate the role of somatic ERBB3 mutations in human cancers.
    • To identify specific hot-spot mutations within ERBB3 that contribute to oncogenesis.
    • To understand the downstream signaling consequences of these ERBB3 mutations.

    Main Methods:

    • Somatic mutation analysis of ERBB3 in a large cohort of human tumors.
    • Functional assays to assess the impact of identified mutations on ERBB3 signaling.
    • Analysis of downstream signaling pathways, including PI3K/AKT and MAPK.

    Main Results:

    • Identified recurrent hot-spot mutations in the ERBB3 gene in a subset of human tumors.
    • Demonstrated that these ERBB3 mutations lead to constitutive activation of oncogenic signaling pathways.
    • Showcased increased tumor cell proliferation and survival in vitro and in vivo models harboring ERBB3 mutations.

    Conclusions:

    • Somatic ERBB3 hot-spot mutations are oncogenic drivers in specific human tumor types.
    • These mutations activate critical pro-tumorigenic signaling cascades.
    • Targeting ERBB3 or its downstream pathways may represent a therapeutic strategy for ERBB3-mutated cancers.